For citations:
Lebedev D.A., Timkina N.V., Karonova T.L., Andreeva A.T., Kokina M.A., Grigorieva A.L., Babenko A.Yu., Grineva E.N. Effect of empagliflozin on phosphorus and calcium metabolism in patients with type 2 diabetes mellitus with preserved kidney function. Osteoporosis and Bone Diseases. 2021;24(1):4-9. (In Russ.) https://doi.org/10.14341/osteo12718

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).